The patient, a man aged 53 years, was first seen in June 1966 with symptoms of frequency of stool (4 to 5/day) without blood and mucus for about one and a half years. His weight had fallen from 48 to 34 kg during the same period. The stools were watery, moderate in quantity, and not offensive. The patient denied any recent or past history of pain in the abdomen or back, heartburn, vomfiting, or haematemesis. Gastric function tests showed a high basal acid secretion consistent with the diagnosis of Zollinger-Ellison syndrome (Table I) . On large doses of oral antacid and anticholinergic drugs throughout the waking hours, neither the diarrhoea nor the weight improved significantly though parenteral anticholinergic treatment effectively reduced acid output (Table II) . Laparotomy was performed in June 1967 with a view to detect and remove any localized pancreatic tumour. A thorough exploration failed to reveal any tumour in the pancreas or duodenum (not opened) or any enlargement of abdominal lymph nodes. The abdomen was closed (as planned) without performing total gastrectomy or blind distal pancreatectomy. High basal acid secretions were again observed in July 1967, and in April and May 1968 . From January 1968 he passed one or two semisolid stools a day and his weight was 44 kg in April 1968. Since May 1968, he has passed one solid stool a day and his weight is increasing (46 kg, November 1968; 48 kg, January 1969) . Achlorhydria after adequate histamine stimulation was noted for the first time in November 1968 and subsequently in January 1969 (Table I ). The patient is now asymptomatic.
FAMILY HISTORY The patient's father died of accidental injury at the age of 35 years and the mother at the age of 55 years (the cause is not known). His sister died at the age of 45 years of pulmonary tuberculosis, one brother died at the age of 65 years (cause unknown), and the other (62 years) is living and healthy. (Fig. 3) ; the mucosal pattern of upper loops of the jejunum was distorted. There was flocculation in the jejunum and rapid transit through the small intestine Fig. 4 (1969) , and gastric and duodenal folds were prominent. Gastric analysis (Tables I  and Il) showed no circulating intrinsic factor antibodies in serum (1969 (Marks, Selzer, Louw, and Bank, 1961; Aoyagi and Summerskill, 1966; Ruppert, Greenberger, Boman, and McCullough, 1967) or excluded the gastric antrum in a postoperative condition (Scobie, McGill, Priestley, and Rovelstad, 1964 Nelsen, Johnson, and Dragstedt, 1961; Shay, Chey, Koide, and Burnett, 1962) or hyperplasia of islet cells may be the only abnormality (Zollinger and McPherson, 1958; Summerskill, 1959) .
In the Zollinger-Ellison syndrome with peptic ulceration (Ellison and Wilson, 1964; Zollinger and Grant, 1964) chronic diarrhoea occurs in about 30 to 40 % of patients and it may precede peptic ulceration by one to six years (Zollinger and Ellison, 1955; Summerskill, 1959) . About 7 to 10% of patients with the Zollinger-Ellison syndrome suffer from diarrhoea (and gastric hypersecretion) only and peptic ulceration does not occur (Ellison and Wilson, 1964) . Furthermore, hypokalaemia is observed in more than 50% of patients with chronic diarrhoea and the Zollinger-Ellison syndrome (Ellison and Wilson, 1964) . These observations show that chronic diarrhoea and hypokalaemia are features not only of 'pancreatic cholera' but also of the Zollinger-Ellison syndrome. The important distinguishing features of the two syndromes of non-beta islet cell tumours are high basal acid secretion with peptic ulceration in the Zollinger-Ellison syndrome whereas in 'pancreatic cholera' there is hypo-or achlorhydria, watery diarrhoea, and no peptic ulceration. In our patient high basal acid secretion without peptic ulceration for more than two years followed by spontaneous, persistent achlorhydria showed that hypersecretion and subsequent achlorhydria could occur in the same individual over the course of time. It is not unreasonable to suggest that some patients with non-beta cell pancreatic tumour, chronic diarrhoea, and achlorhydria (or low acid secretion) reported in the literature might have the same high basal acid secretion earlier in the illness as was observed in our patient.
Three cases in some respects similar to our patient are reported. Lawrie, Williamson, and Hunt (1962) observed markedly raised acid output (58 m-equiv/15 min) on a test meal in a patient with the ZollingerEllison syndrome and achlorhydria was noted five months after stopping treatment with poldine methyl methosulphate (an anticholinergic agent). The authors attributed achlorhydria in their patient to the 'dramatic response to intensive medical treatment'. It may be assumed that achlorhydria had occurred spontaneously as anticholinergic drugs do not depress gastric acid secretion permanently. Maynard and Point (1958) observed diarrhoea and achlorhydria on two occasions in a patient who subsequently showed high acid output. Even though achlorhydria in these two patients was not confirmed with histamine stimulation these observations suggest that in a patient with non-beta islet cell tumour of the pancreas, if followed for some years, both high basal acid secretion and achlorhydria could be detected. Melnyk, Krippaehna, Benson, and Dunphy (1965) reported markedly diminished basal acid secretion after removal of a small lymph node from the abdomen of a patient suffering from an extensive unresectable non-beta islet cell pancieatic carcinoma. Furthermore, unexplained marked regression of primary and metastatic islet cell tumours of the Zollinger-Ellison syndrome a few years after total gastrectomy has been reported (Friesen, 1967) . Achlorhydria in our patient has obviously resulted from anatomical damage to parietal cells, as gastric biopsy in 1969 showed severe, atrophic gastritis and the absence of parietal cells. Marked infiltration with lymphocytes, plasma, and polymorphonuclear cells suggest that perhaps some inflammatory or immunological process is involved in causing atrophic gastritis. Specific antibodies were detected in rabbits after injection of C-terminal tetiapeptide amide of gastrin conjugated with gamma globulin (McGuigan, 1967) . Since antibodies against Cterminal tetrapeptide react specifically with human gastrin, porcine gastrin, or cholecystokinin-pancreozymin (McGuigan, 1968) , antibodies (if formed) against pentagastrin may neutralize the action of circulating gastrin. Our patient, secreting large amounts of acid for mote than two years, developed achlorhydria within a few months after an injection of pentagastrin (Table I) . Whether this sequence of events was accidental or resulted from the formation of specific antibodies against pentagastrin (a foreign substance) is not clear. Would it not be worthwhile to inject pentagastrin (? conjugated with gamma globulin) repeatedly in patients with the ZollingerEllison syndrome with a view to forming antibodies and thus provide an effective medical treatment for this serious disease?
